All News from Accelerate Diagnostics

All News

Accelerate Diagnostics Launches Investor Portal to Website

Jan 31, 2014 — Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today announced that it has launched a new investor relations portal on its website and will be using this portal to update investors on meaningful events and information going […]

Continue reading ›

Accelerate Diagnostics, Inc. Names Mark C. Miller to Board of Directors

Nov 06, 2013 — Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that Mark C. Miller has been appointed to its Board of Directors. Mr. Miller currently serves as Executive Chairman and director of Stericycle (SRCL) where he was Chief […]

Continue reading ›

Accelerate Diagnostics Announces Final Results of Rights Offering

Aug 13, 2013 — Accelerate Diagnostics, Inc. (AXDX), announced today that it has completed its previously announced rights offering. Through broad participation from both insiders and non-insider investors, the Company raised $20,000,000, including proceeds from a standby commitment made by Abeja Ventures, LLC. Stockholders subscribed for a total of 1,871,410 shares of the Company’s common stock pursuant to their […]

Continue reading ›

Accelerate Diagnostics Announces Final Terms of Rights Offering

Jul 12, 2013 — Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today the final terms of its previously announced $20,000,000 rights offering. The Company anticipates that the rights offering will commence with the distribution of the final prospectus and related […]

Continue reading ›

Accelerate Diagnostics Appoints Chief Commercial Officer

Jul 01, 2013 — Accelerate Diagnostics, Inc. (AXDX), today announced that it has appointed Pete Bantock to the position of Chief Commercial Officer, effective today. Most recently Pete was Sr. Vice President and General Manager of Ventana Medical Systems’ North American Commercial Operations. Previously, Pete was the General Manager of Spring Bioscience, a division of Ventana. Prior to Spring, […]

Continue reading ›

Accelerate Diagnostics Joins the Russell 2000® Index

Jul 01, 2013 — Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today announced that it has joined the Russell 2000®, Russell 3000®, and Russell Global Indexes following Russell’s reconstitution of a comprehensive set of U.S. and global equity indexes. “We are […]

Continue reading ›

Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders

Jun 04, 2013 — Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today announced that it has filed a Registration Statement on Form S-3 with the Securities and Exchange Commission (the “SEC”) for a rights offering to existing holders of its common […]

Continue reading ›

Accelerate Diagnostics, Inc. Names Frank J. M. ten Brink to Board of Directors

Mar 06, 2013 — Accelerate Diagnostics, Inc. (AXDX), a developer of automated diagnostic systems for same-shift identification and antibiotic resistance testing of bacterial and fungal pathogens, announced today that Frank J.M. ten Brink has been appointed to its board of directors. Mr. ten Brink has more than 16 years of finance, accounting and merger & acquisition experience in high-growth […]

Continue reading ›

Accelerate Diagnostics goes to NASDAQ

Dec 12, 2012 — Accelr8 Technology Corporation (NYSE MKT: AXK) announced today that its common stock has been approved by The NASDAQ Stock Market, LLC for listing on the NASDAQ Capital Market. The Company expects to commence trading on NASDAQ under the ticker symbol “AXDX” on Wednesday, December 26, 2012. Until such date, the Company’s common stock will continue […]

Continue reading ›

Accelr8 Announces New Management

Jun 27, 2012 — Accelr8 Technology Corporation (NYSE MKT: AXK) today announced the appointment of Lawrence Mehren as President and Chief Executive Officer and a member of the Board of Directors. Most recently, Mr. Mehren was Head of Global Business of Ventana Medical Systems and Roche Tissue Diagnostics, managing its four business units, as well as Spring Biosciences, and […]

Continue reading ›